0001567619-21-004330.txt : 20210217 0001567619-21-004330.hdr.sgml : 20210217 20210217193544 ACCESSION NUMBER: 0001567619-21-004330 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210214 FILED AS OF DATE: 20210217 DATE AS OF CHANGE: 20210217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Underberg Sharon E. CENTRAL INDEX KEY: 0001630353 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19271 FILM NUMBER: 21647025 MAIL ADDRESS: STREET 1: EASTMAN KODAK COMPANY STREET 2: 343 STATE STREET CITY: ROCHESTER STATE: NY ZIP: 14650 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE CENTRAL INDEX KEY: 0000874716 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 010393723 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 BUSINESS PHONE: 2075560300 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 FORMER COMPANY: FORMER CONFORMED NAME: IDEXX CORP / DE DATE OF NAME CHANGE: 19600201 4 1 doc1.xml FORM 4 X0306 4 2021-02-14 0 0000874716 IDEXX LABORATORIES INC /DE IDXX 0001630353 Underberg Sharon E. C/O IDEXX LABORATORIES, INC. WESTBROOK ME 04092 0 1 0 0 SVP, Gen. Counsel & Secretary Common Stock 2021-02-14 4 M 0 483 0 A 1386 D Common Stock 2021-02-14 4 M 0 217 0 A 1603 D Common Stock 2021-02-14 4 F 0 208 544.08 D 1395 D Non-Qualified Stock Option (right-to-buy) 544.08 2021-02-14 4 A 0 5119 A 2031-02-13 Common Stock 5119 5119 D Incentive Stock Option (right-to-buy) 544.08 2021-02-14 4 A 0 183 A 2031-02-13 Common Stock 183 183 D Restricted Stock Unit 2021-02-14 4 A 0 551 A Common Stock 551 3349 D Restricted Stock Unit 2021-02-14 4 M 0 453 D Common Stock 453 2866 D Restricted Stock Unit 2021-02-14 4 M 0 217 D Common Stock 217 2649 D Includes a total of 29 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on September 30, 2020 and December 31, 2020. Closing price of Issuer common stock on the NASDAQ Global Select Market on February 12, 2021. Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2022. Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on the fourth anniversary of the date of grant. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021. Not applicable. /s/ Lily J. Lu, Attorney-in-Fact for Sharon E. Underberg 2021-02-17